Optical Biometry Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

The optical biometry devices market is estimated to grow at a CAGR of 4.1% during the forecast period from 2024 to 2030. The market for optical biometry devices is experiencing significant growth due to several key factors. The increasing prevalence of eye disorders such as cataracts, glaucoma, and refractive errors is driving demand for precise diagnostic tools. An aging population, which is more susceptible to these conditions, further contributes to this demand. Technological advancements are continuously enhancing the accuracy and usability of optical biometry devices, making them more attractive to healthcare providers. Additionally, rising healthcare expenditure, particularly in developed regions, supports greater investment in advanced medical equipment. Improved treatment outcomes associated with the use of these devices also drive their adoption. Growing awareness about early diagnosis and treatment, along with better accessibility to advanced diagnostic tools, contributes to market growth during the forecast period from 2024 to 2030.

Optical Biometry Devices Market Dynamics:

According to latest available data provided by the World Glaucoma Association approximately 7.6 million individuals globally were identified with glaucoma in 2020. This figure is anticipated to skyrocket to 111.8 million by 2040. Notably, in developed countries, as much as 90% of glaucoma cases remain undiagnosed, and half of the population is oblivious to their condition. Glaucoma, often symptomatically silent, stands as a primary contributor to irreversible blindness on a global scale. The latest available projections from the World Glaucoma Association indicate that by 2040, over 11 million people will experience bilateral blindness due to glaucoma.

According to the European Commission (2023), in 2021, the European Union saw cataract surgery as the predominant surgical procedure, with a significant 4.32 million operations performed across EU nations. Additionally, as per the same source France had the highest rate of cataract surgery per 100,000 population in 2021 estimating 1,417 per 100,000 population followed by Austria (1,340 PER 100,000 population). Furthermore, as per the study conducted by the International Agency for the Prevention of Blindness (IAPB) in 2020, the global population affected by moderate to severe cataracts was 83,475,182. The need for precision in measuring the eye’s dimensions and determining the correct intraocular lens (IOL) power has driven the demand for advanced Optical Biometry Devices. These devices provide critical measurements such as axial length, anterior chamber depth, and corneal curvature, which are essential for successful surgical outcomes.

Another key factor behind the growth of the Optical Biometry Devices market is rise in product launch activities, and acquisitions, for example, in October 2023, Bausch + Lomb Corporation announced that they launched their product SeeNa™ Optical Biometry and Topography System in the United States
Therefore all the factors mentioned above are expected to push forward the growth of the Optical Biometry Devices Market during the forecast of 2024 to 2030.

However, the high cost of the ophthalmic biometers, and the Inability to measure AL and ACD in eyes with densely opacified media, may restrict the growth of the overall Optical Biometry Devices market.

Optical Biometry Devices Market Segment Analysis:

Optical Biometry Devices Market by Product Type (Swept-Source OCT Biometers, Optical Low Coherence Reflectometry (OLCR)-Based Biometers and Others), Application (Cataract, Glaucoma, Refractive Error, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the overall Optical Biometry Devices Market, the Swept-Source OCT Biometers category is expected to hold the largest share in the year 2023. This can be attributed to the wide applications and advantages provided by the Swept-Source OCT Biometers. Swept-source optical Coherence Tomography (SS-OCT) biometers are cutting-edge tools utilized in ophthalmology for assessing eye structures and conditions. They offer several distinct advantages. Firstly, SS-OCT biometers boast enhanced penetration and imaging quality. By employing a longer wavelength light source, they can penetrate dense ocular media like cataracts and hemorrhages, resulting in clearer imaging of deeper eye structures such as the choroid and sclera. Additionally, their high-resolution images facilitate detailed visualization of critical structures like the retina and optic nerve.

Further, these devices are marked by their speed and efficiency. SS-OCT systems perform scans swiftly, reducing the time needed for a complete assessment. This not only enhances patient comfort but also increases throughput in busy clinical settings. Their real-time data acquisition capabilities enable immediate visualization and assessment, crucial for timely clinical decision-making. SS-OCT biometers excel in comprehensive data collection. They can measure the entire axial length of the eye and simultaneously capture various parameters such as corneal curvature, anterior chamber depth, lens thickness, and axial length, providing a comprehensive overview of the eye's anatomy. Moreover, these devices ensure improved accuracy and reliability. Their advanced technology guarantees highly reproducible measurements, essential for monitoring disease progression and preoperative and postoperative assessments. Additionally, they are less dependent on operator skill, ensuring consistent and accurate measurements across different users and settings. However, these advantages make the SS-OCT biometers a preferred choice for surgeons and healthcare facilities.

For example- In March 2021, Alcon released its new ARGOS SS-OCT biometer for Australia and New Zealand.

Therefore, owing to the applications and advantages of Swept-Source OCT Biometers, all of the above factors are expected to drive the growth of the Swept-Source OCT Biometers, thereby propelling the overall growth of the optical biometry devices market during the forecast period from 2024 to 2030.

North America Is Expected To Dominate The Overall Optical Biometry Devices Market:

Among all the regions, North America is expected to hold the largest share in the global Optical Biometry Devices Market in 2023. The North American market for optical biometry devices is witnessing significant growth, driven by a multitude of factors. Chief among these is the rising prevalence of eye conditions such as cataracts and glaucoma, alongside an increasing number of refractive errors. Coupled with these health trends is the growing expenditure on healthcare across the region, which further propels the market forward. In addition, the active involvement of major industry players and their relentless pursuit of product innovation play a crucial role in this market expansion. This combination of rising healthcare needs, technological advancements, and strategic industry initiatives collectively accelerates the growth of the optical biometry device market in North America. As a result, there is a robust response to the growing demand for state-of-the-art treatments and progressive eye care technologies.

For instance, according to data provided by the Centers for Disease Control and Prevention (CDC) (2024) released data indicating that in 2019, more than 3 million Americans were affected by glaucoma, a condition that can lead to irreversible vision loss if left untreated. Projections from the CDC suggest a concerning trend, with the number of cases expected to skyrocket to approximately 6.3 million by the year 2050. This forecast underscores the urgent need for proactive measures to address this growing public health challenge, including increased awareness, improved access to screening and treatment, and investment in research to develop more effective interventions.

The increasing number of people with glaucoma is likely to make optical biometry devices more popular. These devices use light to measure different parts of the eye, helping doctors spot glaucoma early and keep an eye on it over time. As technology gets better, these devices will become even more accurate and useful. With more people needing personalized treatment for glaucoma, companies making these devices have a big opportunity to grow. By improving their devices, they can help doctors take better care of people with glaucoma and meet the rising demand for eye care.

Additionally, the growing number of product launches and partnerships in the field of optical biometry devices by prominent firms in the United States is significantly contributing to the advancement of the overall future market of such devices. As an example, in October 2023, Bausch + Lomb Corporation unveiled their SeeNa™ Optical Biometry and Topography System for the U.S. market.

Therefore, increasing product approvals, and launches of the product along with the presence of key players, among others is expected to boost the growth of the Optical Biometry Devices Market in the North America region during the forecast period from 2024 to 2030.

Optical Biometry Devices Market Key Players:

Some of the key market players operating in the Optical Biometry Devices Market include Alcon Inc., Beye, LLC, BAUSCH + LOMB INCORPORATED, NIDEK CO., LTD., TOMEY CORPORATION, Topcon Corporation, Visionix, Ziemer Ophthalmic Systems AG, Haag-Streit Group, East Valley Ophthalmology, and others.

Recent Developmental Activities In The Optical Biometry Devices Market:

• In April 2024, Carl Zeiss Meditec AG announced the completion of its acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, based in Paris, France. This acquisition strengthens ZEISS Medical Technology's extensive ophthalmic product lineup and its suite of digitally connected workflow solutions.
• In February 2023, NIDEK CO., LTD. unveiled the AL-Scan M Optical Biometer along with the MV-1 Myopia Viewer software. The AL-Scan M is designed to measure axial length, a key parameter recognized in clinical and scientific literature for its effectiveness in predicting and monitoring the progression of myopia.
• In January 2023, Alcon once again led the field with the most significant surgical ophthalmic presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2023 Annual Meeting, held from May 5-8 in San Diego.

Key Takeaways From The Optical Biometry Devices Market Report Study

• Market size analysis for current Optical Biometry Devices Market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Optical Biometry Devices Market.
• Various opportunities available for the other competitor in the Optical Biometry Devices Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Optical Biometry Devices Market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Optical Biometry Devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Optical Biometry Devices Market Report Study

• Optical Biometry products providers
• Research organizations and consulting companies
• Optical Biometry Devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in optical biometry devices
• Various end-users who want to know more about the optical biometry devices market and the latest technological developments in the optical biometry devices market.

Frequently Asked Questions For The Optical Biometry Devices Market:

1. What are optical biometry devices?

Optical biometery devices are sophisticated instruments used in ophthalmology to measure various parameters of the eye, particularly for procedures like cataract surgery and intraocular lens (IOL) implantation.

2. What is the market for global optical biometry devices?

The optical biometry devices market is estimated to grow at a CAGR of 4.1% during the forecast period from 2024 to 2030.

3. What are the drivers for the global optical biometry devices market?

The market for optical biometry devices is experiencing significant growth due to several key factors. The increasing prevalence of eye disorders such as cataracts, glaucoma, and refractive errors is driving demand for precise diagnostic tools. An aging population, which is more susceptible to these conditions, further contributes to this demand. Technological advancements are continuously enhancing the accuracy and usability of optical biometry devices, making them more attractive to healthcare providers. Additionally, rising healthcare expenditure, particularly in developed regions, supports greater investment in advanced medical equipment. Improved treatment outcomes associated with the use of these devices also drive their adoption. Growing awareness about early diagnosis and treatment, along with better accessibility to advanced diagnostic tools, contributes to market growth during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global optical biometry devices market?

Some of the key market players operating in the Optical Biometry Devices Market include Alcon Inc., Beye, LLC, BAUSCH + LOMB INCORPORATED, NIDEK CO., LTD., TOMEY CORPORATION, Topcon Corporation, Visionix, Ziemer Ophthalmic Systems AG, Haag-Streit Group, East Valley Ophthalmology, and others.

5. Which region has the highest share in the optical biometry devices market?

The North American market for optical biometry devices is witnessing significant growth, driven by a multitude of factors. Chief among these is the rising prevalence of eye conditions such as cataracts and glaucoma, alongside an increasing number of refractive errors. Coupled with these health trends is the growing expenditure on healthcare across the region, which further propels the market forward. In addition, the active involvement of major industry players and their relentless pursuit of product innovation play a crucial role in this market expansion. This combination of rising healthcare needs, technological advancements, and strategic industry initiatives collectively accelerates the growth of the optical biometry device market in North America. As a result, there is a robust response to the growing demand for state-of-the-art treatments and progressive eye care technologies.


This product will be delivered within 2 business days.